The change in the expression of miR‐125b‐5p and the SIRT3/AMPK/mTOR axis, which was accompanied by the induction of autophagy, could be considered the underlying mechanism of the therapeutic properties of luteolin in confronting osteoporosis. The gene discussed is MTOR; the disease is osteoporosis.